Fundz

Ellipses Pharma eyes London listing via RTO

PRIVATENov 18, 2026

Acquiring Company

London Stock Exchange Group plc (LSEG)

Acquired Company

Ellipses Pharma Limited

New YorkUnited Arab EmiratesFinancial ServicesFinanceLendingBiotechnologyHealth CareMedicalTherapeuticsPharmaceutical

Description

Ellipses Pharma is pursuing a London listing through a reverse takeover deal. The text is largely boilerplate disclaimers from Global Banking & Finance Review and does not identify the acquiring company or give deal terms.

Quick answer

London Stock Exchange Group plc (LSEG) is acquiring Ellipses Pharma Limited, announced November 18, 2026. London Stock Exchange Group plc (LSEG) is based in New York, New York, United States.

How much did London Stock Exchange Group plc (LSEG) pay for Ellipses Pharma Limited?
The deal value was not disclosed.
What does London Stock Exchange Group plc (LSEG) do?
London Stock Exchange Group plc (LSEG) is a leading financial infrastructure and capital markets business, operating a broad range of international equity, bond and derivatives markets.
Where are London Stock Exchange Group plc (LSEG) and Ellipses Pharma Limited based?
London Stock Exchange Group plc (LSEG) is based in New York, New York, United States. Ellipses Pharma Limited is based in United Arab Emirates.

Source: Fundz verified event record.

Other recent acquisitions in Financial Services and Finance

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at London Stock Exchange Group plc (LSEG), and when

When London Stock Exchange Group plc (LSEG) changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day London Stock Exchange Group plc (LSEG) raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at London Stock Exchange Group plc (LSEG), from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at London Stock Exchange Group plc (LSEG). With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

London Stock Exchange Group plc (LSEG)

Location

New York, New York, United States

About

London Stock Exchange Group plc (LSEG) is a leading financial infrastructure and capital markets business, operating a broad range of international equity, bond and derivatives markets.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment London Stock Exchange Group plc (LSEG) makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for London Stock Exchange Group plc (LSEG)'s next move

Learn about Strategic plan

Frequently asked

Who acquired Ellipses Pharma Limited?

Ellipses Pharma Limited was acquired by London Stock Exchange Group plc (LSEG), based in New York. The deal was reported on November 18, 2026. London Stock Exchange Group plc (LSEG) is a leading financial infrastructure and capital markets business, operating a broad range of international equity, bond and derivatives markets. London Stock Exchange Group plc (LSEG) is privately held and operates in Financial Services.

When did London Stock Exchange Group plc (LSEG) acquire Ellipses Pharma Limited?

London Stock Exchange Group plc (LSEG)'s acquisition of Ellipses Pharma Limited was reported on November 18, 2026. Ellipses Pharma is pursuing a London listing through a reverse takeover deal. The text is largely boilerplate disclaimers from Global Banking & Finance Review and does not identify the acquiring company or give deal terms. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Ellipses Pharma Limited do?

Ellipses Pharma Limited is a global drug development company focused on accelerating the development of cancer treatments through an innovative drug development model. It is privately held, operating in Biotechnology, and is based in United Arab Emirates.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.